Evidence map›Paper›PMID 33811315›Full record

ReviewDermatology and therapy2021

Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review.

Paolo Gisondi, Sara Di Leo, Francesco Bellinato, Simone Cazzaniga, Stefano Piaserico, Luigi Naldi

Open access · goldAbstract readReview
In one paragraph

Review in Dermatology and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Prevalence and patterns of cutaneous manifestations in 1245 COVID-19 patients in Japan: a single-centre study.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Article
  7. Cutaneous Manifestations of SARS-CoV-2 Infection.American journal of clinical dermatology · 2022
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Paolo GisondiSection of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy. paolo.gisondi@univr.it.ORCID http://orcid.org/0000-0002-1777-9001
Sara Di LeoDivision of Dermatology, San Bortolo Hospital, Vicenza, Italy.
Francesco BellinatoSection of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
Simone CazzanigaCentro Studi GISED, Bergamo, Italy.
Stefano PiasericoSection of Dermatology, Department of Medicine, University of Padua, Padua, Italy.
Luigi NaldiDivision of Dermatology, San Bortolo Hospital, Vicenza, Italy.
Centro Studi GISED · ITUniversity of Verona · ITOspedale San Bortolo · ITUniversity of Padua · IT

Funding

Fondazione Cariplo ID 1833073 rif. 2020-1363
6 · The paper itself

Abstract

introductionDistinct skin lesions associated with coronavirus disease 2019 (COVID-19) have been described, but data regarding their time of onset during the COVID-19 course are scant. Our objective was to systematically review the studies reporting the time of onset of selected skin lesions with respect to the reported onset of the COVID-19 core symptoms.

methodsA comprehensive search of studies published before 21 January 2021 was performed on MEDLINE via PubMed database using a predefined strategy to identify relevant articles.

resultsOut of 354 references, 87 were selected, reporting a total of 895 patients with skin lesions associated with COVID-19. The most frequent pattern was exanthema (n = 430, 48%), followed by vascular (n = 299, 33%), urticarial (n = 105, 12%) and others (n = 66, 7%). Skin lesions occurred more frequently in the first 4 weeks from the COVID-19 onset (n = 831, 92%), whereas prodromal or late lesions were rarer (n = 69, 8%). The urticarial and exanthema patterns were more frequent in the first 2 weeks. About the vascular pattern some differences were noted among its subtypes. Livedoid lesions occurred mainly in the first 2 weeks, while chilblain-like lesions between weeks 2 and 4. Purpuric/petechial lesions were equally distributed during the first 4 weeks. Several skin manifestations did not fall into the pattern classification, including erythema multiforme, generalized pruritus, Kawasaki disease and others.

conclusionThe diversity in the time of onset of skin lesions as well as their polymorphic nature likely reflects the diversity of the pathogenetic underlying mechanisms. PROSPERO DATABASE REGISTRATION NUMBER: CRD42021236331.

Indexed as

ChilblainCOVID-19LivedoPurpuraSARS-CoV-2UrticariaVaricellaWeal

Identifiers

PMID33811315
PMCPMC8018690
OpenAlexW3146726572

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.